A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)

Clinical trial NCT03815279 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT03815279
Sponsor: Landspitali University Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Smoldering Multiple Myeloma

Start date: 2019-06-24
Primary completion: 2024-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.